Accrued and other current liabilities consist of the following:
March 31,2026
December 31,2025
Compensation expense
$
3,639
9,716
Clinical trial research and development services
5,468
5,335
Manufacturing and other research and development services
2,515
3,774
General and administrative services
297
393
Other
90
80
12,009
19,298
Accrued expenses and other current liabilities.
No definition available.